SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4

Deysi Viviana T. Wong Helder Veras Ribeiro Filho; Carlos Wagner Souza Wanderley; Caio Abner Vitorino Gonçalves Leite; Jonilson Berlink Lima; Alexia Nathália Brígido Assef; Aurilene Gomes Cajado; Gabriela Loiola Ponte Batista; Rafael Holanda González; Karla Oliveira Silva; Luis Philipi Carvalho Borges; Nylane Maria Nunes de Alencar; Diego Veras Wilke; Thiago Mattar Cunha; Ana Carolina Migliorini Figueira; Fernando de Queiroz Cunha; Roberto César P Lima Júnior

Cancer Chemotherapy and Pharmacology Heidelberg v. 84, n. 2, p. 287-298, 2019

Heidelberg 2019

Available at FMRP - Fac. Medicina de Ribeirão Preto    (pcd 3011835 Acervo Digital )(GetIt)